A Study to Compare MK-0941 and Glimepiride in Patients with Type 2 Diabetes on Metformi
Phase 2
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2009/091/000154
- Lead Sponsor
- Merck Sharp and Dohme
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 130
Inclusion Criteria
Patient has type 2 diabetes mellitus
Between the ages of 18 and 70
Exclusion Criteria
Patient has a history of type 1 Diabetes Mellitus or ketoacidosis.
Patient is on a weight loss program and is not in the maintenance phase or is taking weight loss medication.
Patient has had surgery within 30 days of starting the study or has planned major surgery during the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method